Company profile DMAC

DiaMedica Therapeutics Inc
Description of the company is not available.
Quarter analysis & expected interestLast update: November 05 2023 08:49:04.

After 34 days of this quarter the interest is at 98.0. Based on that we can calculate that during remaining 58 days it will total up to 265.0.
DiaMedica Therapeutics expected interest is significantly higher compared to same quarter last year (+231.2%) but similar to previous quarter.

YearQ1Q2Q3Q4
2018 - - - 126
2019 102
-19.0% QoQ
106
3.9% QoQ
57
-46.2% QoQ
136
7.9% YoY 138.6% QoQ
2020 157
53.9% YoY 15.4% QoQ
26
-75.5% YoY -83.4% QoQ
89
56.1% YoY 242.3% QoQ
157
15.4% YoY 76.4% QoQ
2021 0
-100.0% YoY -100.0% QoQ
27
3.8% YoY inf% QoQ
117
31.5% YoY 333.3% QoQ
105
-33.1% YoY -10.3% QoQ
2022 71
inf% YoY -32.4% QoQ
56
107.4% YoY -21.1% QoQ
21
-82.1% YoY -62.5% QoQ
80
-23.8% YoY 281.0% QoQ
2023 161
126.8% YoY 101.2% QoQ
103
83.9% YoY -36.0% QoQ
206
881.0% YoY 100.0% QoQ
98
22.5% YoY -52.4% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and DiaMedica Therapeutics search interestLast update: November 05 2023 08:49:04.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 05 2023 08:49:04.

The average 5 years interest of DiaMedica Therapeutics was 7.7 per week.
The last year interest of DiaMedica Therapeutics compared to the last 5 years has changed by 51.04%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 42.35%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DM199 clinical trials to provide analysis

Correlation between past revenue and DM199 clinical trials search interest

There is not enough data for DM199 clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DM199 clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 05 2023 08:49:20.

After 34 days of this quarter the interest is at 290.0. Based on that we can calculate that during remaining 58 days it will total up to 785.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2018 - - - 100
2019 360
260.0% QoQ
327
-9.2% QoQ
478
46.2% QoQ
457
357.0% YoY -4.4% QoQ
2020 433
20.3% YoY -5.3% QoQ
382
16.8% YoY -11.8% QoQ
560
17.2% YoY 46.6% QoQ
431
-5.7% YoY -23.0% QoQ
2021 356
-17.8% YoY -17.4% QoQ
553
44.8% YoY 55.3% QoQ
412
-26.4% YoY -25.5% QoQ
533
23.7% YoY 29.4% QoQ
2022 586
64.6% YoY 9.9% QoQ
656
18.6% YoY 11.9% QoQ
493
19.7% YoY -24.8% QoQ
621
16.5% YoY 26.0% QoQ
2023 642
9.6% YoY 3.4% QoQ
659
0.5% YoY 2.6% QoQ
594
20.5% YoY -9.9% QoQ
290
-53.3% YoY -51.2% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Chronic kidney disease treatment search interestLast update: November 05 2023 08:49:20.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 05 2023 08:49:21.

The average 5 years interest of Chronic kidney disease treatment was 38.17 per week.
The last year interest of Chronic kidney disease treatment compared to the last 5 years has changed by 27.67%.
The interest for Chronic kidney disease treatment is trending.
The last year interest is quite higher compared to 5 years ago. It has increased by 73.42%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 20:23:13.

After 39 days of this quarter the interest is at 187.0. Based on that we can calculate that during remaining 52 days it will total up to 436.0.
Acute ischemic stroke treatment expected interest is significantly higher compared to previous quarter (+110.6%) and same quarter last year (+49.8%).

YearQ1Q2Q3Q4
201964
128
100.0% QoQ
43
-66.4% QoQ
166
286.0% QoQ
2020 216
237.5% YoY 30.1% QoQ
95
-25.8% YoY -56.0% QoQ
184
327.9% YoY 93.7% QoQ
90
-45.8% YoY -51.1% QoQ
2021 256
18.5% YoY 184.4% QoQ
79
-16.8% YoY -69.1% QoQ
216
17.4% YoY 173.4% QoQ
175
94.4% YoY -19.0% QoQ
2022 160
-37.5% YoY -8.6% QoQ
239
202.5% YoY 49.4% QoQ
188
-13.0% YoY -21.3% QoQ
302
72.6% YoY 60.6% QoQ
2023 291
81.9% YoY -3.6% QoQ
210
-12.1% YoY -27.8% QoQ
195
3.7% YoY -7.1% QoQ
207
-31.5% YoY 6.2% QoQ
2024 187
-35.7% YoY -9.7% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Acute ischemic stroke treatment search interestLast update: February 08 2024 20:23:12.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 20:23:14.

The average 5 years interest of Acute ischemic stroke treatment was 14.14 per week.
The last year interest of Acute ischemic stroke treatment compared to the last 5 years has changed by 34.37%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 104.52%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 20:23:19.

After 39 days of this quarter the interest is at 227.0. Based on that we can calculate that during remaining 52 days it will total up to 530.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019384
554
44.3% QoQ
538
-2.9% QoQ
554
3.0% QoQ
2020 563
46.6% YoY 1.6% QoQ
673
21.5% YoY 19.5% QoQ
581
8.0% YoY -13.7% QoQ
538
-2.9% YoY -7.4% QoQ
2021 506
-10.1% YoY -5.9% QoQ
593
-11.9% YoY 17.2% QoQ
466
-19.8% YoY -21.4% QoQ
507
-5.8% YoY 8.8% QoQ
2022 636
25.7% YoY 25.4% QoQ
744
25.5% YoY 17.0% QoQ
546
17.2% YoY -26.6% QoQ
775
52.9% YoY 41.9% QoQ
2023 647
1.7% YoY -16.5% QoQ
791
6.3% YoY 22.3% QoQ
622
13.9% YoY -21.4% QoQ
707
-8.8% YoY 13.7% QoQ
2024 227
-64.9% YoY -67.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Inflammatory disease treatment search interestLast update: February 08 2024 20:23:18.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 20:23:20.

The average 5 years interest of Inflammatory disease treatment was 46.56 per week.
The last year interest of Inflammatory disease treatment compared to the last 5 years has changed by 13.42%.
The interest for Inflammatory disease treatment is seasonal.
The last year interest is quite higher compared to 5 years ago. It has increased by 22.16%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 20:23:25.

After 39 days of this quarter the interest is at 100.0. Based on that we can calculate that during remaining 52 days it will total up to 233.0.
DiaMedica Therapeutics stock expected interest is significantly higher compared to previous quarter (+468.3%) and same quarter last year (+inf%).

YearQ1Q2Q3Q4
201914
98
600.0% QoQ
21
-78.6% QoQ
41
95.2% QoQ
2020 28
100.0% YoY -31.7% QoQ
40
-59.2% YoY 42.9% QoQ
59
181.0% YoY 47.5% QoQ
24
-41.5% YoY -59.3% QoQ
2021 15
-46.4% YoY -37.5% QoQ
39
-2.5% YoY 160.0% QoQ
44
-25.4% YoY 12.8% QoQ
59
145.8% YoY 34.1% QoQ
2022 66
340.0% YoY 11.9% QoQ
39
0.0% YoY -40.9% QoQ
29
-34.1% YoY -25.6% QoQ
36
-39.0% YoY 24.1% QoQ
2023 0
-100.0% YoY -100.0% QoQ
11
-71.8% YoY inf% QoQ
68
134.5% YoY 518.2% QoQ
41
13.9% YoY -39.7% QoQ
2024 100
inf% YoY 143.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and DiaMedica Therapeutics stock search interestLast update: February 08 2024 20:23:25.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 20:23:26.

The average 5 years interest of DiaMedica Therapeutics stock was 3.34 per week.
The last year interest of DiaMedica Therapeutics stock compared to the last 5 years has changed by 26.65%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 26.27%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DiaMedica Therapeutics careers to provide analysis

Correlation between past revenue and DiaMedica Therapeutics careers search interest

There is not enough data for DiaMedica Therapeutics careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DiaMedica Therapeutics careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DiaMedica Therapeutics reviews to provide analysis

Correlation between past revenue and DiaMedica Therapeutics reviews search interest

There is not enough data for DiaMedica Therapeutics reviews to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DiaMedica Therapeutics reviews to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DiaMedica Therapeutics Minnesota to provide analysis

Correlation between past revenue and DiaMedica Therapeutics Minnesota search interest

There is not enough data for DiaMedica Therapeutics Minnesota to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DiaMedica Therapeutics Minnesota to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DiaMedica Therapeutics -stock -company to provide analysis

Correlation between past revenue and DiaMedica Therapeutics -stock -company search interest

There is not enough data for DiaMedica Therapeutics -stock -company to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DiaMedica Therapeutics -stock -company to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for DMAC
Earnings date: 2024-03-26 After close
Company name: DiaMedica Therapeutics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-12T20:15:00Z

BusinessWire
DiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

2026-05-06T20:30:00Z

BusinessWire
DiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights

2026-04-30T12:25:00Z

BusinessWire
DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026

2026-03-30T20:45:00Z

BusinessWire
DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights

2026-03-30T08:56:22Z

Analyst Upgrades
Top Wall Street Forecasters Revamp DiaMedica Therapeutics Expectations Ahead Of Q4 Earnings

2026-03-23T12:25:00Z

BusinessWire
DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026

2026-03-05T12:35:00Z

BusinessWire
DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia

2026-02-24T14:23:00Z

BusinessWire
DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences

2025-12-18T13:45:00Z

BusinessWire
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA

2025-11-14T14:29:37Z

Analyst Upgrades
Cantor Fitzgerald Initiates Coverage On DiaMedica Therapeutics with Overweight Rating, Announces Price Target of $25

2025-11-12T21:30:00Z

BusinessWire
DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights

2025-11-10T13:15:00Z

BusinessWire
DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London

2025-11-06T21:15:00Z

BusinessWire
DiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025

2025-10-15T16:48:26-04:00

SEC
SCHEDULE 13G/A Form - [Amend] Statement of Beneficial Ownership by Certain Investors - DiaMedica Therapeutics Inc. (0001401040) (Subject)

2025-09-29T20:15:00Z

BusinessWire
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)